Literature DB >> 33183160

Shortening Velocity Causes Myosin Isoform Shift in Human Engineered Heart Tissues.

Ronald Ng1, Lorenzo R Sewanan1, Paul Stankey1, Xia Li1, Yibing Qyang2,3,4,5, Stuart Campbell1.   

Abstract

Entities:  

Keywords:  cardiac output; heart; myosin heavy chains; stem cells

Mesh：

Substances：

Year:  2020        PMID： 33183160      PMCID： PMC7855774          DOI： 10.1161/CIRCRESAHA.120.316950

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  4 in total

Review 1.  It takes "heart" to win: what makes the heart powerful?

Authors:  Kerry S McDonald; Todd J Herron
Journal:  News Physiol Sci       Date:  2002-10

2.  Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes.

Authors:  Natalie Weber; Kristin Schwanke; Stephan Greten; Meike Wendland; Bogdan Iorga; Martin Fischer; Cornelia Geers-Knörr; Jan Hegermann; Christoph Wrede; Jan Fiedler; Henning Kempf; Annika Franke; Birgit Piep; Angelika Pfanne; Thomas Thum; Ulrich Martin; Bernhard Brenner; Robert Zweigerdt; Theresia Kraft
Journal:  Basic Res Cardiol       Date:  2016-10-14       Impact factor: 17.165

3.  Contractile work directly modulates mitochondrial protein levels in human engineered heart tissues.

Authors:  Ronald Ng; Lorenzo R Sewanan; Allison L Brill; Paul Stankey; Xia Li; Yibing Qyang; Barbara E Ehrlich; Stuart G Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-08       Impact factor: 4.733

4.  Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues.

Authors:  Andrea Leonard; Alessandro Bertero; Joseph D Powers; Kevin M Beussman; Shiv Bhandari; Michael Regnier; Charles E Murry; Nathan J Sniadecki
Journal:  J Mol Cell Cardiol       Date:  2018-03-28       Impact factor: 5.000
  4 in total
  4 in total

1.  Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy.

Authors:  Muhammad Riaz; Jinkyu Park; Lorenzo R Sewanan; Yongming Ren; Jonas Schwan; Subhash K Das; Pawel T Pomianowski; Yan Huang; Matthew W Ellis; Jiesi Luo; Juli Liu; Loujin Song; I-Ping Chen; Caihong Qiu; Masayuki Yazawa; George Tellides; John Hwa; Lawrence H Young; Lei Yang; Charles C Marboe; Daniel L Jacoby; Stuart G Campbell; Yibing Qyang
Journal:  Circulation       Date:  2022-04-06       Impact factor: 39.918

2.  Mavacamten preserves length-dependent contractility and improves diastolic function in human engineered heart tissue.

Authors:  Lorenzo R Sewanan; Shi Shen; Stuart G Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-15       Impact factor: 4.733

3.  Physiological calcium combined with electrical pacing accelerates maturation of human engineered heart tissue.

Authors:  Shi Shen; Lorenzo R Sewanan; Stephanie Shao; Saiti S Halder; Paul Stankey; Xia Li; Stuart G Campbell
Journal:  Stem Cell Reports       Date:  2022-08-04       Impact factor: 7.294

4.  Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation.

Authors:  Lorenzo R Sewanan; Jinkyu Park; Michael J Rynkiewicz; Alice W Racca; Nikolaos Papoutsidakis; Jonas Schwan; Daniel L Jacoby; Jeffrey R Moore; William Lehman; Yibing Qyang; Stuart G Campbell
Journal:  J Gen Physiol       Date:  2021-07-28       Impact factor: 4.086
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.